medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 3

<< Back Next >>

Rev Mex Pediatr 2023; 90 (3)

Impact COVID-19 pandemic on respiratory diseases and circulation of viruses in the pediatric emergency department

Vera-Valencia G, Rendón-Macías ME, López-Enriquez C, Casillas-Casillas MC, Escobedo-Berumen L, Ortega-Zárate PN, Buenfil-Rebolledo N, Silva-Ramírez H
Full text How to cite this article 10.35366/114202

DOI

DOI: 10.35366/114202
URL: https://dx.doi.org/10.35366/114202

Language: Spanish
References: 23
Page: 97-102
PDF size: 239.40 Kb.


Key words:

virus, COVID-19, pandemic, acute respiratory infection, children, emergency department.

ABSTRACT

Introduction: acute respiratory infections (ARI) are the main cause of care in emergency departments. Isolation measures due to the COVID-19 pandemic could have changed the prevalence of viruses that cause ARI. Objective: to determine the possible impact of the COVID-19 pandemic on the prevalence of viral agents in patients with ARI. Material and methods: an analysis was carried out of the emergency visits of pediatric patients with upper or lower respiratory symptoms, in whom virus detection was performed, during the period from 2019 to 2022. The study was carried out in a private hospital. Trends were analyzed through adjusted correlations, whether linear, quadratic, or cubic. Results: during 2019, 1,456 patients with ARI were treated, by 2020 it dropped to 660, in 2021 to 281, and in 2022 it rose to 872. The prevalence of viruses in the four years showed two patterns of behavior: one with a quadratic trend (respiratory syncytial virus A, coronavirus 229E and NL63, parainfluenza 4 and enterovirus) and another cubic trend (respiratory syncytial virus B, adenovirus, coronavirus OC43, parainfluenza 3 and rhinovirus). Conclusions: the COVID-19 pandemic had an impact on a lower frequency of ARI care in the emergency room, as well as on the change in the prevalence of respiratory viruses.


REFERENCES

  1. Florencia-Lucion M, Juárez-del Valle M, Pejito M, Orqueda AS, Romero-Bollon L, Mistchenko AS et al. Impacto del COVID-19 en la circulación de virus respiratorios en un hospital pediátrico: una ausencia esperada. Arch Argent Pediatr. 2022; 120(2): 99-105.

  2. Rivas-Ruiz R, Flores-Pulido AA, Pacheco-Rosas DO, Moreno-Noguez M, Roy García I, Moreno-Espinosa S. Características clínicas y factores de riesgo para infección severa en niños con COVID-19. Rev Acad Mex Ped. 2022; 2: 7-15.

  3. Leal-Castro AL. Efecto de las medidas preventivas durante la pandemia: más allá del SARS CoV-2. Biomédica. 2021; 41(Supl. 2): 5-7.

  4. Kruizinga MD, Peeters D, van Veen M, van Houten M, Wieringa J, Noordzij JG et al. The impact of lockdown on pediatric ED visits and hospital admissions during the COVID19 pandemic: a multicenter analysis and review of the literature. Eur J Pediatr. 2021; 180(7): 2271-2279.

  5. Rámirez-Sandoval P. El frío, los virus y las infecciones respiratorias. Rev Acad Mex Ped. 2022; 2: 16-23.

  6. Vizcarra-Ugalde S, Rico-Hernández M, Monjarás-Ávila C, Bernal-Silva S, Garrocho-Rangel ME, Ochoa-Pérez UR et al. Intensive care unit admission and death rates of infants admitted with respiratory syncytial virus lower respiratory tract infection in Mexico. Pediatr Infect Dis J. 2016; 35(11): 1199-1203.

  7. Zheng Z, Pitzer VE, Shapiro ED, Bont LJ, Weinberger DM. Estimation of the timing and intensity of reemergence of respiratory syncytial virus following the COVID-19 pandemic in the US. JAMA Netw Open. 2021; 4(12): e2141779.

  8. Hartnett KP, Kite-Powell A, DeVies J, Coletta MA, Boehmer TK, Adjemian J et al. Impact of the COVID-19 Pandemic on Emergency Department Visits - United States, January 1, 2019-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(23): 699-704.

  9. Nair H, Simoes EA, Rudan I, Gessner BD, Azziz-Baumgartner E, Zhang JSF et al. Severe acute lower respiratory infections working group. global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet. 2013; 381 (9875): 1380-1390.

  10. Martinón-Torres F, González-Barcala FJ. ¿Dónde se esconde el virus respiratorio sincitial? Arch Bronconeumol. 2022; 58(4): 298-299.

  11. Miyama T, Iritani N, Nishio T, Ukai T, Satsuki Y, Miyata H, Shintani A et al. Seasonal shift in epidemics of respiratory syncytial virus infection in Japan. Epidemiol Infect. 202; 149: e55.

  12. Rose EB, Wheatley A, Langley G, Gerber S, Haynes A. Respiratory syncytial virus seasonality - United States, 2014-2017. MMWR Morb Mortal Wkly Rep. 2018; 67(2): 71-76.

  13. Kadambari S, Goldacre R, Morris E, Goldacre M J, Pollard A J. Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study. BMJ. 2022; 376: e067519.

  14. Marcone Débora N, Carballal G, Ricarte C, Echavarria M. Diagnóstico de virus respiratorios utilizando un sistema automatizado de PCR múltiples (FilmArray) y su comparación con métodos convencionales. Rev Argent Microbiol. 2015; 47(1): 29-35.

  15. Le Corre N, Pérez R, Vizcaya C, Martínez-Valdebenito C, López T, Monge M, Alarcón R. Relevancia de la co-detección de virus respiratorios en la severidad de la infección respiratoria aguda en niños hospitalizados. Andes Pediatr. 2021; 92(3): 349-358.

  16. Britton PN, Hu N, Saravanos G, Shrapnel J, Davis J, Snelling T et al. COVID-19 public health measures and respiratory syncytial virus. Lancet Child Adolesc Health. 2020; 4(11): e42-e43.

  17. González-García N, Castilla-Peón MF, Solórzano Santos F, Jiménez-Juárez RN, Martínez Bustamante ME, Minero-Hibert MA, Garduño-Espinosa J. Covid-19 incidence and mortality by age strata and comorbidities in Mexico City: a focus in the pediatric population. Front Public Health. 2021; 9: 738423.

  18. Freymuth F. Virus respiratorio sincitial, metapneumovirus y virus parainfluenza humanos: cuadro clínico y fisiopatología. EMC Pediatr. 2007; 42(4): 1-9.

  19. Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021; 12(1): 1001-1108.

  20. Branche AR, Falsey AR. Parainfluenza virus infection. Semin Respir Crit Care Med. 2016; 37(4): 538-554.

  21. Li Y, Reeves RM, Wang X, Bassat Q, Brooks WA, Cohen C, Moore DP, et al; RSV Global Epidemiology Network; RESCEU investigators. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health. 2019; 7(8): e1031-e1045.

  22. Azekawa S, Namkoong H, Mitamura K, Kawaoka Y, Saito F. Co-infection with SARS-CoV-2 and influenza A virus. IDCases. 2020; 20: e00775.

  23. Vargas-Ponce KG, Salas-López JA, Llanos-Tejada FK, Morales-Avalos A. Coinfección de Covid-19 e influenza: reporte de cinco casos en un hospital peruano. Rev Fac Med Hum. 2020; 20(4): 738-742.




Figure 1
Figure 2
Table 1

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2023;90